source
- Colorado judge blocks 70% price cap on Amgen's Enbrel, citing potential economic injuryA U.S. District Court in Colorado issued a preliminary injunction that stops a state‑imposed 70% price cap on Amgen's autoimmune drug Enbrel. The ruling was made by Judge Daniel Domenico, who grant…
- Revolution Medicines reports promising early data for KRAS drug combo, plans Phase 3 in pancreatic cancerRevolution Medicines presented early-stage results that support moving forward with a Phase 3 study of a combination of two KRAS-targeted agents in pancreatic cancer. The data, shown for the first…